Immune checkpoint blockade therapy in head and neck cancer: a review
Head and neck cancer (HNC) is a common malignant tumor, carrying a poor prognosis, and despite advances in oncology, this rate has not improved significantly for decades. It has recently been evaluated that the immunologic checkpoint inhibitors become a novel promising strategic immunotherapy in the...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
Update Dental College,
2018-12-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|